# Plant Response Biotech

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/plant-response-biotech

- Industry: Biotechnology
- Headquarters: Raleigh, US
- Website: www.plantresponse.com
- Total disclosed funding: $13M
- Latest round: Series B (Dec 9, 2018)
- Investors on record: 7

## About

Plant Response Biotech, Inc. specializes in innovative agricultural solutions to enhance crop productivity and sustainability through advanced biotechnological applications and products.Plant Response Biotech, Inc. was formed in November 2019 through a merger between PlantResponse Biotech, S.L. and Koch Biological Solutions, LLC, aiming to integrate their capabilities and assets. The company is headquartered in Raleigh, US. Tom Snipes serves as the CEO. In December 2021, the Mosaic Company acquired Plant Response Biotech, Inc. for an undisclosed amount, further enhancing its presence in soil-health products. The company has participated in 4 deals, with the most recent being a Series B funding round of USD 6.90 mn led by Bayer Venture Investments, Middleland Capital, Novozymes, Yara Growth Ventures, and iSelect Fund Management.Plant Response Biotech, Inc. focuses on developing advanced biological solutions and products that improve soil health and crop yields. Their offerings are designed to optimize plant nutrition and enhance the interactions within the soil microbiome. Targeted primarily at agricultural stakeholders including farmers and agronomists, the products aim to meet regional and crop-specific agricultural needs across North America, South America, and select international markets.Plant Response Biotech, Inc. generates revenue through the sale of its advanced agricultural products and solutions, which include tailored offerings for both large agribusinesses and smallholder farmers. The company emphasizes research-driven methodologies to ensure effective results for its clients, fostering long-term relationships within the agricultural community.The company plans to expand its product line with upcoming innovations aimed at improving soil health and crop yields, leveraging the recent funding from its Series B round completed in December 2021. Plant Response Biotech, Inc. aims to enter new markets across North America and Europe by 2024. The funds raised will support research and development initiatives, focusing on the launch of new products designed to enhance agricultural sustainability and productivity.

## Funding rounds

- Series B, Dec 9, 2018, $6.9M — Middleland Capital, iSelect Fund Management, Novozymes, Bayer Venture Investments, Yara Growth Ventures
- Series A, Nov 25, 2015, $6M — Caixa Capital Risc, Middleland Capital, Monsanto Growth Ventures, Novozymes

## Investors

- Caixa Capital Risc — Series A
- Middleland Capital — Series A, Series B
- Monsanto Growth Ventures (https://capitalatlas.ai/funds/monsanto-growth-ventures) — Series A
- Novozymes — Series A, Series B
- iSelect Fund Management (https://capitalatlas.ai/funds/iselect-fund-management) — Series B
- Bayer Venture Investments — Series B
- Yara Growth Ventures — Series B